Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2019

Open Access 01-12-2019 | Endocarditis | Original investigation

Infective endocarditis according to type 2 diabetes mellitus status: an observational study in Spain, 2001–2015

Authors: José M. de Miguel-Yanes, Rodrigo Jiménez-García, Valentín Hernández-Barrera, Javier de Miguel-Díez, Manuel Méndez-Bailón, Nuria Muñoz-Rivas, Napoleón Pérez-Farinós, Ana López-de-Andrés

Published in: Cardiovascular Diabetology | Issue 1/2019

Login to get access

Abstract

Background

The main aims of this study were to describe trends and outcomes during admission for infective endocarditis (IE) in people ≥ 40 years old with or without type 2 diabetes distributed in five time-periods (2001–2003; 2004–2006; 2007–2009; 2010–2012 and 2013–2015), using Spanish national hospital discharge data.

Methods

We estimated admission rates by diabetes status. We analyzed comorbidity, therapeutic procedures, and outcomes. We built Poisson regression models to compare the adjusted time-trends in admission rates. Type 2 diabetes cases were matched with controls using propensity score matching (PSM). We tested in-hospital mortality (IHM) in logistic regression analyses.

Results

We identified 16,626 hospitalizations in patients aged ≥ 40 years for IE in Spain, 2001–2015. The incidence of IE increased significantly from 6.0/100,000 per year to 13.1/100,000 per year (p < 0.001) in the population with type 2 diabetes, and from 3.9/100,000 per year to 5.5/100,000 per year (p < 0.001) in the population without diabetes, over the study period. The adjusted incidence of IE was 2.2-times higher among patients with diabetes than among those without diabetes (IRR = 2.2; 95% CI 2.1–2.3). People with type 2 diabetes less often underwent heart valve surgery than people without diabetes (13.9% vs. 17.3%; p < 0.001). Although IHM decreased significantly in both groups over time, it represented 20.8% of IE cases among diabetes patients and 19.9% among PSM matched controls (p = 0.337). Type 2 diabetes was not associated with a higher IHM in people admitted to the hospital for IE (OR = 1.1; 95% CI 0.9–1.2).

Conclusion

Incidence rates of IE in Spain, among those with and without T2DM, have increased during the period 2001–2015 with significantly higher incidence rates in the T2DM population. In our population based study and after PSM we found that T2DM was not a predictor of IHM in IE.
Appendix
Available only for authorised users
Literature
1.
go back to reference Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.PubMedPubMedCentralCrossRef Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463–73.PubMedPubMedCentralCrossRef
2.
go back to reference Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS ONE. 2013;8:e82665.PubMedPubMedCentralCrossRef Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, et al. Infective endocarditis epidemiology over five decades: a systematic review. PLoS ONE. 2013;8:e82665.PubMedPubMedCentralCrossRef
3.
go back to reference Olmos C, Vilacosta I, Fernández-Pérez C, Bernal JL, Ferrera C, García-Arribas D, et al. The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol. 2017;70:2795–804.PubMedCrossRef Olmos C, Vilacosta I, Fernández-Pérez C, Bernal JL, Ferrera C, García-Arribas D, et al. The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol. 2017;70:2795–804.PubMedCrossRef
4.
go back to reference Bikdeli B, Wang Y, Kim N, Desai MM, Quagliarello V, Krumholz HM. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62:2217–26.PubMedPubMedCentralCrossRef Bikdeli B, Wang Y, Kim N, Desai MM, Quagliarello V, Krumholz HM. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62:2217–26.PubMedPubMedCentralCrossRef
5.
go back to reference Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012;55:88–93.PubMedCrossRef Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012;55:88–93.PubMedCrossRef
6.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 1980;2016(387):1513–30. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 1980;2016(387):1513–30.
7.
go back to reference Basterra-Gortari FJ, Bes-Rastrollo M, Ruiz-Canela M, Gea A, Martinez-Gonzalez MÁ. Prevalence of obesity and diabetes in Spanish adults 1987–2012. Med Clin. 2017;148:250–6.CrossRef Basterra-Gortari FJ, Bes-Rastrollo M, Ruiz-Canela M, Gea A, Martinez-Gonzalez MÁ. Prevalence of obesity and diabetes in Spanish adults 1987–2012. Med Clin. 2017;148:250–6.CrossRef
8.
go back to reference Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998–2013. JAMA. 2017;317:1652–60.PubMedPubMedCentralCrossRef Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in infective endocarditis in California and New York State, 1998–2013. JAMA. 2017;317:1652–60.PubMedPubMedCentralCrossRef
9.
go back to reference Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890–7.PubMedCrossRef Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia. Eur Heart J. 2010;31:1890–7.PubMedCrossRef
10.
go back to reference Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14:29–34.PubMedCrossRef Delamaire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997;14:29–34.PubMedCrossRef
11.
go back to reference Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906–12.PubMedCrossRef Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341:1906–12.PubMedCrossRef
12.
go back to reference Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, et al. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis. 2010;19:312–20.PubMed Chirillo F, Bacchion F, Pedrocco A, Scotton P, De Leo A, Rocco F, et al. Infective endocarditis in patients with diabetes mellitus. J Heart Valve Dis. 2010;19:312–20.PubMed
13.
go back to reference Kourany WM, Miro JM, Moreno A, Corey GR, Pappas PA, Abrutyn E, et al. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis—Merged Database. Scand J Infect Dis. 2006;38:613–9.PubMedCrossRef Kourany WM, Miro JM, Moreno A, Corey GR, Pappas PA, Abrutyn E, et al. Influence of diabetes mellitus on the clinical manifestations and prognosis of infective endocarditis: a report from the International Collaboration on Endocarditis—Merged Database. Scand J Infect Dis. 2006;38:613–9.PubMedCrossRef
14.
go back to reference Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol. 2012;10:19–32.PubMedCrossRef Tousoulis D, Kampoli AM, Stefanadis C. Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol. 2012;10:19–32.PubMedCrossRef
15.
go back to reference Eringa EC, Serne EH, Meijer RI, Schalkwijk CG, Houben AJHM, Stehouwer CDA, et al. Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord. 2013;14:39–48.PubMedCrossRef Eringa EC, Serne EH, Meijer RI, Schalkwijk CG, Houben AJHM, Stehouwer CDA, et al. Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord. 2013;14:39–48.PubMedCrossRef
16.
go back to reference Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102:2842–8.PubMedCrossRef Strom BL, Abrutyn E, Berlin JA, Kinman JL, Feldman RS, Stolley PD, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102:2842–8.PubMedCrossRef
17.
go back to reference Østergaard L, Mogensen UM, Bundgaard JS, Dahl A, Wang A, Torp-Pedersen C, et al. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis. Int J Cardiol. 2019;278:280–4.PubMedCrossRef Østergaard L, Mogensen UM, Bundgaard JS, Dahl A, Wang A, Torp-Pedersen C, et al. Duration and complications of diabetes mellitus and the associated risk of infective endocarditis. Int J Cardiol. 2019;278:280–4.PubMedCrossRef
18.
go back to reference Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41:2127–35.PubMedCrossRef Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41:2127–35.PubMedCrossRef
19.
go back to reference Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2015;385:1219–28.PubMedCrossRef Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000–13: a secular trend, interrupted time-series analysis. Lancet. 2015;385:1219–28.PubMedCrossRef
20.
go back to reference Movahed MR, Hashemzadeh M, Jamal MM. Increased prevalence of infectious endocarditis in patients with type II diabetes mellitus. J Diabetes Complicat. 2007;21:403–6.CrossRef Movahed MR, Hashemzadeh M, Jamal MM. Increased prevalence of infectious endocarditis in patients with type II diabetes mellitus. J Diabetes Complicat. 2007;21:403–6.CrossRef
21.
go back to reference Mistiaen WP. What are the main predictors of in-hospital mortality in patients with infective endocarditis: a review. Scand Cardiovasc J. 2018;52:58–68.PubMedCrossRef Mistiaen WP. What are the main predictors of in-hospital mortality in patients with infective endocarditis: a review. Scand Cardiovasc J. 2018;52:58–68.PubMedCrossRef
22.
go back to reference Wei XB, Liu YH, Huang JL, Chen XL, Yu DQ, Tan N, et al. Prediabetes and diabetes are both risk factors for adverse outcomes in infective endocarditis. Diabet Med. 2018;35:1499–507.PubMedCrossRef Wei XB, Liu YH, Huang JL, Chen XL, Yu DQ, Tan N, et al. Prediabetes and diabetes are both risk factors for adverse outcomes in infective endocarditis. Diabet Med. 2018;35:1499–507.PubMedCrossRef
23.
go back to reference Olmos C, Vilacosta I, Pozo E, Fernández C, Sarriá C, López J, et al. Prognostic implications of diabetes in patients with left-sided endocarditis: findings from a large cohort study. Medicine. 2014;93:114–9.PubMedPubMedCentralCrossRef Olmos C, Vilacosta I, Pozo E, Fernández C, Sarriá C, López J, et al. Prognostic implications of diabetes in patients with left-sided endocarditis: findings from a large cohort study. Medicine. 2014;93:114–9.PubMedPubMedCentralCrossRef
25.
go back to reference Chu VH, Cabell CH, Benjamin DK Jr, Kuniholm EF, Fowler VG Jr, Engemann J, Sexton DJ, Corey GR, Wang A. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109:1745–9.PubMedCrossRef Chu VH, Cabell CH, Benjamin DK Jr, Kuniholm EF, Fowler VG Jr, Engemann J, Sexton DJ, Corey GR, Wang A. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109:1745–9.PubMedCrossRef
26.
go back to reference Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40:527–35.PubMedCrossRef Leone S, Ravasio V, Durante-Mangoni E, Crapis M, Carosi G, Scotton PG, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40:527–35.PubMedCrossRef
27.
go back to reference Bishara J, Peled N, Samra Z, Sagie A, Leibovici L, Pitlik S. Infective endocarditis in diabetic and non-diabetic patients. Scand J Infect Dis. 2004;36:795–8.PubMedCrossRef Bishara J, Peled N, Samra Z, Sagie A, Leibovici L, Pitlik S. Infective endocarditis in diabetic and non-diabetic patients. Scand J Infect Dis. 2004;36:795–8.PubMedCrossRef
28.
go back to reference Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis. 2011;11:48.PubMedPubMedCentralCrossRef Fedeli U, Schievano E, Buonfrate D, Pellizzer G, Spolaore P. Increasing incidence and mortality of infective endocarditis: a population-based study through a record-linkage system. BMC Infect Dis. 2011;11:48.PubMedPubMedCentralCrossRef
29.
go back to reference Duval X, Alla F, Doco-Lecompte T, Le Moing V, Delahaye F, Mainardi JL, et al. Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J. 2007;28:59–64.PubMedCrossRef Duval X, Alla F, Doco-Lecompte T, Le Moing V, Delahaye F, Mainardi JL, et al. Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality. Eur Heart J. 2007;28:59–64.PubMedCrossRef
30.
go back to reference Nunes MCP, Guimarães-Júnior MH, Murta Pinto PHO, Coelho RMP, Souza Barros TL, Faleiro Maia NPA, et al. Outcomes of infective endocarditis in the current era: early predictors of a poor prognosis. Int J Infect Dis. 2018;68:102–7.PubMedCrossRef Nunes MCP, Guimarães-Júnior MH, Murta Pinto PHO, Coelho RMP, Souza Barros TL, Faleiro Maia NPA, et al. Outcomes of infective endocarditis in the current era: early predictors of a poor prognosis. Int J Infect Dis. 2018;68:102–7.PubMedCrossRef
31.
go back to reference Joffre J, Dumas G, Aegerter P, Dubée V, Bigé N, Preda G, et al. Epidemiology of infective endocarditis in French intensive care units over the 1997–2014 period-from CUB-Réa Network. Crit Care. 2019;23:143.PubMedPubMedCentralCrossRef Joffre J, Dumas G, Aegerter P, Dubée V, Bigé N, Preda G, et al. Epidemiology of infective endocarditis in French intensive care units over the 1997–2014 period-from CUB-Réa Network. Crit Care. 2019;23:143.PubMedPubMedCentralCrossRef
33.
go back to reference Morita Y, Haruna T, Haruna Y, Nakane E, Yamaji Y, Hayashi H, et al. Thirty-day readmission after infective endocarditis: analysis from a nationwide readmission database. J Am Heart Assoc. 2019;8:e011598.PubMedPubMedCentralCrossRef Morita Y, Haruna T, Haruna Y, Nakane E, Yamaji Y, Hayashi H, et al. Thirty-day readmission after infective endocarditis: analysis from a nationwide readmission database. J Am Heart Assoc. 2019;8:e011598.PubMedPubMedCentralCrossRef
34.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRefPubMed
36.
go back to reference Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399–424.CrossRef Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399–424.CrossRef
37.
go back to reference D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.PubMedCrossRef D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.PubMedCrossRef
39.
go back to reference Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150–61.PubMedCrossRef Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10:150–61.PubMedCrossRef
42.
go back to reference Sullenberger AL, Avedissian LS, Kent SM. Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia. J Heart Valve Dis. 2005;14:23–8.PubMed Sullenberger AL, Avedissian LS, Kent SM. Importance of transesophageal echocardiography in the evaluation of Staphylococcus aureus bacteremia. J Heart Valve Dis. 2005;14:23–8.PubMed
43.
go back to reference Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med. 2019;380:415–24.PubMedCrossRef Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med. 2019;380:415–24.PubMedCrossRef
44.
go back to reference Bustamante-Munguira J, Mestres CA, Alvarez P, Figuerola-Tejerina A, Eiros Bachiller R, Gómez-Sánchez E, et al. Surgery for acute infective endocarditis: epidemiological data from a Spanish nationwide hospital-based registry. Interact Cardiovasc Thorac Surg. 2018;27:498–504.PubMedCrossRef Bustamante-Munguira J, Mestres CA, Alvarez P, Figuerola-Tejerina A, Eiros Bachiller R, Gómez-Sánchez E, et al. Surgery for acute infective endocarditis: epidemiological data from a Spanish nationwide hospital-based registry. Interact Cardiovasc Thorac Surg. 2018;27:498–504.PubMedCrossRef
45.
go back to reference Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59:1968–76.PubMedCrossRef Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59:1968–76.PubMedCrossRef
46.
go back to reference Ahtela E, Oksi J, Porela P, Ekström T, Rautava P, Kytö V. Trends in occurrence and 30-day mortality of infective endocarditis in adults: population-based registry study in Finland. BMJ Open. 2019;9:e026811.PubMedPubMedCentralCrossRef Ahtela E, Oksi J, Porela P, Ekström T, Rautava P, Kytö V. Trends in occurrence and 30-day mortality of infective endocarditis in adults: population-based registry study in Finland. BMJ Open. 2019;9:e026811.PubMedPubMedCentralCrossRef
47.
go back to reference Mata-Cases M, Franch-Nadal J, Real J, Mauricio D. Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007–2013 in Catalonia: a population-based study. BMJ Open. 2016;6:e012463.PubMedPubMedCentralCrossRef Mata-Cases M, Franch-Nadal J, Real J, Mauricio D. Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007–2013 in Catalonia: a population-based study. BMJ Open. 2016;6:e012463.PubMedPubMedCentralCrossRef
48.
go back to reference Sambola A, Fernández-Hidalgo N, Almirante B, Roca I, González-Alujas T, Serra B, et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol. 2010;106:92–8.PubMedCrossRef Sambola A, Fernández-Hidalgo N, Almirante B, Roca I, González-Alujas T, Serra B, et al. Sex differences in native-valve infective endocarditis in a single tertiary-care hospital. Am J Cardiol. 2010;106:92–8.PubMedCrossRef
49.
go back to reference Aksoy O, Meyer LT, Cabell CH, Kourany WM, Pappas PA, Sexton DJ. Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patients. Scand J Infect Dis. 2007;39:101–7.PubMedCrossRef Aksoy O, Meyer LT, Cabell CH, Kourany WM, Pappas PA, Sexton DJ. Gender differences in infective endocarditis: pre- and co-morbid conditions lead to different management and outcomes in female patients. Scand J Infect Dis. 2007;39:101–7.PubMedCrossRef
50.
go back to reference Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2016;22:336–45.PubMedCrossRef Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2016;22:336–45.PubMedCrossRef
51.
go back to reference Schneeweiss S, Robicsek A, Scranton R, Zuckerman D, Solomon DH. Veteran’s affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol. 2007;60:397–409.PubMedCrossRef Schneeweiss S, Robicsek A, Scranton R, Zuckerman D, Solomon DH. Veteran’s affairs hospital discharge databases coded serious bacterial infections accurately. J Clin Epidemiol. 2007;60:397–409.PubMedCrossRef
52.
go back to reference Ribera A, Marsal JR, Ferreira-González I, Cascant P, Cascant P, Pons JM, Mitjavila F, et al. Predicting in-hospital mortality with coronary bypass surgery using hospital discharge data: comparison with a prospective observational study. Rev Esp Cardiol. 2008;61:843–52.PubMedCrossRef Ribera A, Marsal JR, Ferreira-González I, Cascant P, Cascant P, Pons JM, Mitjavila F, et al. Predicting in-hospital mortality with coronary bypass surgery using hospital discharge data: comparison with a prospective observational study. Rev Esp Cardiol. 2008;61:843–52.PubMedCrossRef
53.
go back to reference Rodrigo-Rincón I, Martin-Vizcaíno MP, Tirapu-León B, Zabalza-López P, Abad-Vicente FJ, Merino-Peralta A, et al. Usefulness of administrative databases for risk adjustment of adverse events in surgical patients. Cir Esp. 2016;94:165–74.PubMedCrossRef Rodrigo-Rincón I, Martin-Vizcaíno MP, Tirapu-León B, Zabalza-López P, Abad-Vicente FJ, Merino-Peralta A, et al. Usefulness of administrative databases for risk adjustment of adverse events in surgical patients. Cir Esp. 2016;94:165–74.PubMedCrossRef
54.
go back to reference Khokhar B, Jette N, Metcalfe A, Cunningham CT, Quan H, Kaplan GG, et al. Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016;5(6):e009952.CrossRef Khokhar B, Jette N, Metcalfe A, Cunningham CT, Quan H, Kaplan GG, et al. Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016;5(6):e009952.CrossRef
Metadata
Title
Infective endocarditis according to type 2 diabetes mellitus status: an observational study in Spain, 2001–2015
Authors
José M. de Miguel-Yanes
Rodrigo Jiménez-García
Valentín Hernández-Barrera
Javier de Miguel-Díez
Manuel Méndez-Bailón
Nuria Muñoz-Rivas
Napoleón Pérez-Farinós
Ana López-de-Andrés
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2019
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-019-0968-0

Other articles of this Issue 1/2019

Cardiovascular Diabetology 1/2019 Go to the issue